Diagnosis of myelodysplastic syndrome and other myeloid neoplasms requires correlation of clinical, morphologic, and cytogenetic findings, but flow cytometric immunophenotyping method can be useful in assessing myeloid dysmaturation. Dr. Jevremovic describes a new flow cytometric test to detect aberrant patterns of expression in the diagnosis of myelodysplastic syndrome.
Recent Stories for Education
Registration is now open for Mayo Medical Laboratories’ Genetic Testing Forum, Leveraging Genetic Counselors: The Role of Genetic Counselors in Test Utilization Management. The forum will be held July 14 from 12—1 p.m. Central Time.
In this video, Bobbi Pritt, M.D., Consultant in the Clinical Microbiology Laboratory, and Don Flott, Director of Utilization and Integration Services, Mayo Collaborative Services, two of Mayo Clinic’s laboratory leaders, discuss the evolving role of the consumer in health care and laboratory medicine.
Other Posts for Education
- Multi-Gene Panel Testing For Inherited Cardiovascular Disorders [Hot Topic]
- Utilizing the Laboratory Genetic Counselor to Maximize Patient Care
- What to Expect from Leveraging the Laboratory Conference [Video]
- Dengue Virus: A Diagnostic Testing Update [Hot Topic]
- 2015 ASCO Annual Meeting
- 2015 Digestive Disease Week
- Update on Nephrolithiasis Part 2: Risk for Recurrent Stones and Search for Rare Causes of Kidney Stones [Hot Topic]
- Use of Mass Spectrometry to Improve Thyroglobulin Quantitation [Communiqué]
- Update on Nephrolithiasis Part 1: Pathogenic Factors and Treatment [Hot Topic]
- Phlebotomy 2015 Conference [Summary]